Daily News Podcast

Bempedoic acid: funny name, serious LDL lowering

Publish date: March 15, 2019

 

Bempedoic acid safely dropped LDL cholesterol, and now it’s up for FDA approval. Recent trials advance axial spondyloarthritis therapy. Newer antihyperglycemic drugs have distinctive cardiovascular, kidney benefits. And doctors’ prior authorization burden is increasing.
Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

Recommended Reading

A prescription for medicine’s gender inequality
MDedge Neurology
Parental leave inequities: Kirti Magudia and Thomas Ng, Part I
MDedge Neurology
Trump targets abortion by denying family planning funds
MDedge Neurology
Online vitriol’s expansion into doctor discussion sites
MDedge Neurology
Will having fewer primary care physicians shorten Americans’ lifespans?
MDedge Neurology
Cancer-battling breath, Zombie Bambi, and hops as health food
MDedge Neurology
Esketamine gets the green light for depression
MDedge Neurology
Ready for universal hepatitis C testing?
MDedge Neurology
Autism risk with in utero infections
MDedge Neurology
Aspirin and lower risk of COPD flare-up
MDedge Neurology